DayTwo
FranceEntry
2019
Hold
7yr
Status
Active
Who owns DayTwo?
DayTwo is a French Biotech company, currently owned by Cathay Capital since 2019.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Cathay CapitalCathay Innovation Fund II · 2019 · VC
2 ownership periods · full history below
Key facts
HQFrance
SectorBiotech
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2017 · present
Seventure PartnersExited 2024
2017 · 2024(7yr) · Health for Life Capital · 2014 · VC
Seventure Partners exited DayTwo in 2024 after 7 years.
Cathay CapitalActive
2019 · present(7yr) · Cathay Innovation Fund II · 2019 · VC
More from Cathay Innovation Fund II
Other portfolio companies in the same fund.
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns DayTwo?
DayTwo is currently owned by Cathay Capital, through Cathay Innovation Fund II, since 2019.
When did Cathay Capital acquire DayTwo?
Cathay Capital acquired DayTwo in 2019.
Who has owned DayTwo over time?
DayTwo has been through 2 private-equity ownership periods: Seventure Partners · via Health for Life Capital · 2017–2024; Cathay Capital · via Cathay Innovation Fund II · since 2019.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue